Caris Life Sciences to Attend Q4 2025 Investor Conferences
IRVING, Texas, Nov. 17, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine...
Healthcare
AdvaHealth Solutions Announces Global Expansion and Welcomes Industry Veteran Imad Nijim to Its Board
Company enters the U.S. market with a mission to make modern, cloud-native imaging accessible to every provider. SINGAPORE, Nov. 17,...
SOS Technologies and Critical Response Group Announce Critical Integration to Enhance Real-Time Emergency Response and Public Safety
DEERFIELD BEACH, Fla., Nov. 17, 2025 /PRNewswire/ -- SOS Technologies, the innovator behind SmartEAS, the nation's first patented "Detection to...
Study by Incheon National University Could Transform Skin Cancer Detection with Near-Perfect Accuracy
New deep learning system integrates images and clinical details, improving early skin cancer diagnosis and aiding in smart healthcare INCHEON,...
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025
BOTHELL, Wash., Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and...
Basata Taps Former NextGen Healthcare Executive Brandon Theophilus to Lead Growth Strategy
PHOENIX, Nov. 17, 2025 /PRNewswire/ -- Basata, a healthcare technology company specializing in applied artificial intelligence for healthcare operations, has announced today,...
Reason Health Launches ReasonHub to Unlock the Value of Healthcare Knowledge Content
Beta program opens November 17 for organizations struggling to transform unstructured clinical guidelines, quality measures, and PA rules into high-value...
Compassion Center, the Las Vegas Community, and Loved Ones Honor the Life and Immeasurable Legacy of Julie “Nurse Juhlzie” Monteiro with Community Celebrations December 13-14, 2025
It is with the greatest of sadness and the deepest of regret that Compassion Center announces the passing of its...
Butterfly Network Launches Compass AI to Power the Next Generation of POCUS Program Management
Artificial intelligence-powered operating system built for compliant, scalable, revenue-ready POCUS programs.BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--$BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”,...
Veradigm Launches Enhanced Ambient Scribe Capabilities
AI-powered solution includes multilingual support, structured diagnosis code recommendations, and clinical decision insights support tools for Veradigm EHR customersCHICAGO--(BUSINESS WIRE)--Veradigm®...
GE HealthCare announces Flyrcado milestone: Strong pilot results drive broader rollout at CVAUSA
CVAUSA, the largest network of private cardiology groups in the U.S., plans to broadly adopt Flyrcado in line with its...
Dr. Shajira Mohammed Joins Ankle & Foot Centers of America, Serving Emory Midtown and Lithonia Offices
Dr. Mohammed brings advanced training in wound care, sports injuries, and reconstructive foot and ankle surgery to two key metro...
VSEE Health, Inc. Delivers Robust Q3 2025 Revenue Growth Amid Telehealth Expansion: Total Revenues Reach $3.98 Million, Up 19% Year-Over-Year
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering provider of AI-powered...
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Cash expected to fund operations into the second half of 2026Company focused on advancing next-generation anti-cancer therapies derived from well-established...
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17,...
NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has...
Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
~Funding supports Phase 3 clinical development of PF614 and continued innovation in abuse- and overdose-resistant analgesics~ SAN DIEGO, CA /...
Jaguar Health Reports Third Quarter 2025 Financials: Net Q3 2025 Revenue Up Approximately 4% Versus Net Q2 2025 Revenue
Initial results of ongoing investigator-initiated proof-of-concept trial demonstrate crofelemer can potentially extend the lives of infants born with intestinal failure...
Medicus Pharma Ltd. Announces Filing of FDA Commissioner’s National Priority Voucher Application (CNPV) for SKNJCT-003 to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
SKNJCT-003 Doxorubicin containing Microneedle Array (D-MNA) clinical development program to non-invasively treat BCC aligns with national priorities of public health...
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in...